Primary leiomyosarcoma of the breast was a rare malignant tumor. Due to the extremely low morbidity and insufficient understanding of its imageological characteristics, there was a risk of misdiagnosis. In this case report, we presented the features of conventional US, elastography, automated breast volume scanner (ABVS), computed tomography (CT), and pathological findings of a case of primary leiomyosarcoma of the breast. A 74-year-old woman detected a mass of the left breast by palpation. Both ultrasound and CT revealed a solid mass in the outer quadrant of the left breast. After admission, she underwent a modified radical unilateral mastectomy under general anesthesia (resection of the lesion with left breast reserved). Furthermore, the intraoperative frozen section revealed malignant spindle cells, and the postoperative histopathology revealed primary leiomyosarcoma of the breast. After discharge, the patient was generally in good condition after the procedure and was asked to seek medical treatment in the oncology department. Findings on various imaging examinations and clinical data were carefully evaluated. Additionally, we also reviewed the associated kinds of literature. We reported the features of conventional US, elastography, ABVS, CT, and pathological findings of a rare case of primary leiomyosarcoma of the breast. Overall, our findings indicated that the above-mentioned features generally predict malignancy. However, compared to other malignant breast lesions, the features of this case were not specific enough.
Objective: To develop a High-frequency ultrasound (HFUS)-based predictive nomogram integrating clinical and ultrasound features for distinguishing malignant from benign skin tumors. Methods: This retrospective study enrolled 185 patients who underwent preoperative HFUS examination for skin tumors. Patients were randomly divided into training (n=130; 73 malignant, 57 benign) and validation (n=55; 31 malignant, 24 benign) cohorts. Clinical characteristics and ultrasound features were systematically analyzed. Univariate and multivariate logistic regression analyses were used to identify independent predictors of malignancy, which were incorporated into a nomogram. Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results: Malignant tumors demonstrated significantly greater multilayer involvement, irregular margins, heterogeneous echogenicity, raised surface morphology, and abundant intralesional vascularity compared to benign tumors (all P<0.001). Multivariate analysis identified five independent predictors of malignancy: advanced age (OR = 1.01, 95% CI: 1.00 - 1.01), multilayer involvement (OR = 1.19, 95% CI: 1.12 - 1.26), unclear margins (OR = 1.36, 95% CI: 1.21 - 1.54), raised surface morphology (OR = 1.10, 95% CI: 1.01 - 1.21), and heterogeneous echogenicity (OR = 1.09, 95% CI: 0.99 - 1.21). The nomogram achieved area under the curve (AUC) values of 0.98 (95% CI 0.95-1.00) in the training cohort and 0.98 (95% CI 0.95-1.00) in the validation cohort. Conclusions: HFUS provides valuable information for preoperative evaluation of skin tumors. The nomogram demonstrates good diagnostic performance and clinical utility for distinguishing malignant from benign skin tumors.
Background and Clinical Significance: Cutaneous Rosai-Dorfman disease (CRDD) is a rare, benign histiocytic proliferative disorder, accounting for approximately 3% of all Rosai-Dorfman disease (RDD) cases. Currently, the diagnosis of CRDD relies on invasive pathological examination due to the absence of reliable non-invasive alternatives. This case series evaluates the potential utility of high-frequency ultrasound (HFUS) as an adjunctive diagnostic tool for CRDD. Case Presentation: We present three CRDD cases, correlating HFUS features with histopathology. All cases showed hypoechoic lesions with varying infiltration depths and morphologies, though no specific diagnostic features were identified. HFUS clearly delineated involvement of the dermal and subcutaneous layers, assessed morphological characteristics like contour regularity and border definition, and evaluated vascularity. This information is crucial for clinical decision-making. HFUS also demonstrated value in therapeutic follow-up. In Case 1, it objectively showed a reduction in lesion size and decreased internal vascularity, providing clear evidence of treatment response. Conclusions: Although HFUS cannot independently diagnose CRDD and histopathology remains the gold standard, it serves as a valuable complementary tool. HFUS allows evaluation of deeper tissue structures, infiltration depth, and vascularity. As a non-invasive modality, it is useful for treatment monitoring, therapy guidance, and prognosis assessment. Integrating HFUS into the CRDD workflow enables more comprehensive and precise management.
Objectives: Unlike other body parts, unclarified lesions at the end of extremities have unique challenges due to their small size and interference. Traditional imaging methods struggle with low resolution. HFUS enhances resolution, offering a potential diagnostic value. Methods: From January 2019 to October 2023, the clinical and HFUS data of patients with unclarified lesions at the end of extremities were retrospectively analyzed. Independently, the diagnosis was made using two diagnostic modes (Mode A: only clinical information; Mode B: clinical and HFUS information). The diagnostic performance of the two modes was evaluated across different classification methods. Results: For all lesions, the correct rate of Mode B was higher than that of Mode A (52.8% vs. 18.4%, p < 0.001), and the indeterminate rate decreased by 43.0%. For benign lesions (51.0% vs. 18.2%), subungual lesions (40.8% vs. 21.1%), non-subungual lesions (55.6% vs. 17.8%), and common cases (60.9% vs. 20.3%), the diagnostic correct rate of Mode B was also higher than that of Mode A (all p < 0.05). However, there was no significant difference in rare lesions (9.8% vs. 4.9%) and malignant lesions (62.9% vs. 19.4%) between the two modes (both p > 0.05). Moreover, the indeterminate rate for all categories of lesions significantly diminished. Otherwise, Mode B demonstrated strong performance for malignant lesions (85.7% vs. 42.9%, p < 0.001). Conclusions: Adding HFUS can significantly improve the accuracy of diagnosing unclarified lesions at the end of extremities and reduce uncertainty, especially for benign and common lesions. HFUS has also demonstrated better performance in screening for malignant lesions.